Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
- Status
- TERMINATED
- Phase
- PHASE2
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era
- Status
- COMPLETED
- Phase
- PHASE3
Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
- Status
- WITHDRAWN
- Phase
- PHASE2
Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- UNKNOWN
- Phase
- PHASE2
Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
- Status
- WITHDRAWN
- Phase
- PHASE2
the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs
- Status
- COMPLETED
- Phase
- PHASE1
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1